Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables.
Clin Proteomics
; 20(1): 52, 2023 Nov 21.
Article
en En
| MEDLINE
| ID: mdl-37990292
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Año:
2023
Tipo del documento:
Article